CD14 and colorectal carcinoma: In summary, when comparing intermediate CD14++CD16+ monocytes and CD14++CD16+TIE2+ TEMs in the blood of 32 healthy subjects and 61 CRC patients, we found that intermediate monocytes as opposed to TEMs were significantly elevated in disease.